We are live on
!
Find out more
OC
Oarsman Capital Portfolio holdings
AUM
$806M
1-Year Est. Return
19.96%
This Fund
S&P 500
This Quarter
Est. Return
+4.24%
1 Year Est. Return
+19.96%
3 Year Est. Return
+61.37%
5 Year Est. Return
+74.92%
10 Year Est. Return
+242.94%
AUM
$139M
AUM Growth
+$3.08M
(+2.3%)
Cap. Flow
-$1.25M
Cap. Flow
% of AUM
-0.9%
Top 10 Holdings %
Top 10 Hldgs %
20.66%
Holding
174
New
8
Increased
49
Reduced
91
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco CEF Income Composite ETF
PCEF
|
+$258K |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$230K |
| 3 |
SCHR
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$217K |
| 4 |
Schwab US Mid-Cap ETF
SCHM
|
+$215K |
| 5 |
CXP
COLUMBIA PROPERTY TRUST, INC.
CXP
|
+$206K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BABZ
PIMCO BUILD AMERICA BOND FD ETF
BABZ
|
+$616K |
| 2 |
IBM
IBM
|
+$397K |
| 3 |
Range Resources
RRC
|
+$265K |
| 4 |
ConocoPhillips
COP
|
+$246K |
| 5 |
Newmont
NEM
|
+$220K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.23% |
| 2 | Technology | 11.5% |
| 3 | Industrials | 9.02% |
| 4 | Consumer Staples | 7.86% |
| 5 | Financials | 5.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
GE Aerospace
GE
$367B
| $4.28M | 3.08% |
35,298
-1,265
| -3% | -$156K |
|
|
WBA
2
DELISTED
Walgreens Boots Alliance
WBA
| $3.46M | 2.49% |
45,423
+1,270
| +3% | +$84.9K |
|
3
Johnson & Johnson
JNJ
$634B
| $3.1M | 2.24% |
29,695
-443
| -1% | -$46.7K |
|
4
Apple
AAPL
$4.89T
| $3.09M | 2.23% |
112,068
-1,068
| -0.9% | -$29.1K |
|
5
RPM International
RPM
$13.7B
| $2.79M | 2.01% |
54,918
-2,844
| -5% | -$132K |
|
6
Procter & Gamble
PG
$343B
| $2.52M | 1.82% |
27,677
-253
| -0.9% | -$22.3K |
|
7
Vanguard Mega Cap Growth ETF
MGK
$31.9B
| $2.44M | 1.76% |
150,000
-2,935
| -2% | -$46.7K |
|
8
Microsoft
MSFT
$2.84T
| $2.37M | 1.71% |
51,104
+280
| +0.6% | +$13.1K |
|
|
FISV
9
Fiserv Inc
FISV
$27.2B
| $2.34M | 1.69% |
65,922
-650
| -1% | -$22.3K |
|
10
PepsiCo
PEP
$186B
| $2.28M | 1.64% |
24,076
-227
| -0.9% | -$21.8K |
|
11
Alphabet (Google) Class C
GOOG
$3.9T
| $2.21M | 1.59% |
83,930
+1,023
| +1% | +$27.4K |
|
12
Intel
INTC
$464B
| $2.04M | 1.47% |
56,198
-927
| -2% | -$32.3K |
|
13
Vanguard High Dividend Yield ETF
VYM
$81.1B
| $2M | 1.44% |
29,114
-5
| -0% | -$339 |
|
14
Kimberly-Clark
KMB
$36.4B
| $2M | 1.44% |
17,301
-985
| -5% | -$109K |
|
15
Gilead Sciences
GILD
$161B
| $1.95M | 1.41% |
20,703
+1,201
| +6% | +$124K |
|
16
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
| $1.87M | 1.35% |
15,687
+149
| +1% | +$17.8K |
|
17
Alliant Energy
LNT
$19.4B
| $1.86M | 1.34% |
56,048
-640
| -1% | -$19.8K |
|
18
Medtronic
MDT
$107B
| $1.86M | 1.34% |
25,760
-183
| -0.7% | -$12.7K |
|
19
VF Corp
VFC
$6.68B
| $1.74M | 1.26% |
24,720
-85
| -0.3% | -$5.62K |
|
20
Chevron
CVX
$388B
| $1.74M | 1.26% |
15,533
+636
| +4% | +$72.3K |
|
21
MGE Energy Inc
MGEE
$3.11B
| $1.65M | 1.19% |
36,122
-650
| -2% | -$28.2K |
|
22
AbbVie
ABBV
$458B
| $1.61M | 1.16% |
24,629
-315
| -1% | -$19.9K |
|
23
Novartis
NVS
$295B
| $1.59M | 1.14% |
19,128
-235
| -1% | -$19.5K |
|
24
Colgate-Palmolive
CL
$72.6B
| $1.58M | 1.14% |
22,899
-195
| -0.8% | -$13.2K |
|
25
Berkshire Hathaway Class B
BRK.B
$1.07T
| $1.56M | 1.13% |
10,424
+39
| +0.4% | +$5.63K |
|
Similar funds
RIM
BCM
GCM
CL
DWA
AF
OWA
BDWCC
Oarsman Capital's Q4 2014 Portfolio in Review
As of Q4 2014, Oarsman Capital held 174 positions worth $139M, up 2.3% from $136M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Oarsman Capital's Q4 2014 filing shows 8 new, 49 increased, 91 reduced and 5 closed positions. Its largest new stake was Invesco CEF Income Composite ETF: 10,715 shares worth $253K. The largest sale was PIMCO BUILD AMERICA BOND FD ETF, an estimated $616K.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.
- Oarsman Capital's largest Q4 2014 buy was Invesco CEF Income Composite ETF: 10,715 shares worth $253K.
- Oarsman Capital added most to Vanguard FTSE Developed Markets ETF in Q4 2014, an estimated $230K increase.
- Oarsman Capital's biggest Q4 2014 reduction was IBM, cutting an estimated $397K.
- Oarsman Capital fully exited PIMCO BUILD AMERICA BOND FD ETF in Q4 2014, selling an estimated $616K.
- Oarsman Capital's ten largest holdings make up 21% of its $139M portfolio in Q4 2014.
- Oarsman Capital opened 8 new positions and closed 5 in Q4 2014.
- Oarsman Capital's portfolio value rose 2.3% quarter-over-quarter to $139M.
Based on Oarsman Capital's 13F filing for Q4 2014, filed 6 Feb 2015.